Moreover, the decrease in mTOR levels via miR-144 exacerbates brain damage and enhances pro-inflammatory responses in mouse models of intracerebral hemorrhage, suggesting the miR-144/mTOR pathway as a promising target for intracerebral hemorrhage (ICH) treatment (Yu et al., 2017). This evidence concerns the gene MTOR and intracerebral hemorrhage.